FerGene Stock

www.fergene.comHealthcare / BioTech & PharmaFounded: 2019

FerGene is a gene therapy company dedicated to creating and delivering innovative solutions for bladder cancer. The company's goal is to harness the promise of gene therapy to develop a novel treatment for non-muscle invasive bladder cancer.

Register To Buy and Sell Shares

For more details on financing and valuation for FerGene, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access FerGene’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like FerGene.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About FerGene’s Stock

Can you buy FerGene’s stock?
FerGene is not publicly traded on NYSE or NASDAQ in the U.S. To buy FerGene’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell FerGene’s stock?
Yes, you can sell stock of a private company like FerGene. Forge can help you sell your FerGene stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is FerGene’s stock price?
FerGene is a privately held company and therefore does not have a public stock price. However, you may access FerGene’s private market stock price with Forge Data.
What is FerGene’s stock ticker symbol?
FerGene does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.